Thomas Stankovich - Chief Financial Officer at ReShape Lifesciences Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
RSLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas Stankovich since 10/10/2024

Holdings reported by Thomas Stankovich for ReShape Lifesciences Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.001 par value per share 22.9K $6.2K $0.27 Oct 25, 2023 Direct
Common Stock, $0.001 par value per share 22.8K $5.69K $0.25 May 31, 2024 Direct

Transactions reported by Thomas Stankovich for ReShape Lifesciences Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.